Moberg Pharma AB (publ)
STO:MOB

Watchlist Manager
Moberg Pharma AB (publ) Logo
Moberg Pharma AB (publ)
STO:MOB
Watchlist
Price: 11.84 SEK -6.55%
Market Cap: 552.8m SEK
Have any thoughts about
Moberg Pharma AB (publ)?
Write Note

Net Margin
Moberg Pharma AB (publ)

-461.6%
Current
-2 654%
Average
4.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-461.6%
=
Net Income
-22.8m
/
Revenue
4.9m

Net Margin Across Competitors

Country Company Market Cap Net
Margin
SE
Moberg Pharma AB (publ)
STO:MOB
542.6m SEK
-462%
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY
-79%
US
Eli Lilly and Co
NYSE:LLY
788.1B USD
20%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
-4%
DK
Novo Nordisk A/S
CSE:NOVO B
3.4T DKK
35%
US
Johnson & Johnson
NYSE:JNJ
384.8B USD
17%
US
Merck & Co Inc
NYSE:MRK
259.4B USD
22%
CH
Roche Holding AG
SIX:ROG
215.3B CHF
20%
UK
AstraZeneca PLC
LSE:AZN
171.2B GBP
13%
CH
Novartis AG
SIX:NOVN
184.8B CHF
33%
US
Pfizer Inc
NYSE:PFE
160.4B USD
7%
Country SE
Market Cap 542.6m SEK
Net Margin
-462%
Country JP
Market Cap 776 550.9T JPY
Net Margin
-79%
Country US
Market Cap 788.1B USD
Net Margin
20%
Country UK
Market Cap 440.4B GBP
Net Margin
-4%
Country DK
Market Cap 3.4T DKK
Net Margin
35%
Country US
Market Cap 384.8B USD
Net Margin
17%
Country US
Market Cap 259.4B USD
Net Margin
22%
Country CH
Market Cap 215.3B CHF
Net Margin
20%
Country UK
Market Cap 171.2B GBP
Net Margin
13%
Country CH
Market Cap 184.8B CHF
Net Margin
33%
Country US
Market Cap 160.4B USD
Net Margin
7%

Profitability Report

View the profitability report to see the full profitability analysis for Moberg Pharma AB (publ).

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-461.6%
=
Net Income
-22.8m
/
Revenue
4.9m
What is the Net Margin of Moberg Pharma AB (publ)?

Based on Moberg Pharma AB (publ)'s most recent financial statements, the company has Net Margin of -461.6%.